# NowDiagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nowdiagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Springdale, US
- Website: www.nowdx.com/
- Total disclosed funding: $38M
- Latest round: Series B (Jul 9, 2024)
- Investors on record: 3

## About

Founded in 2014 and based in Arkansas, US, NowDiagnostics, Inc. focuses on diagnostic testing in the healthcare industry. As of 2024, the company is led by its CEO, Robert Weigle. In January 2024, NowDiagnostics, Inc. raised USD 15 million in Series B funding from DigitalDx Ventures and Labcorp Ventures. As of 2024, the company has a presence in over 10 countries.

The company offers a range of tests that can diagnose a variety of common conditions, illnesses, and diseases using just a single drop of blood. Its portfolio of test kits includes the COVID-19 test, HCG test, syphilis test, acetaminophen test, H-Fabp test, HIV test, methanol dip test, salicylate test, and others. In addition, NowDiagnostics offers a range of screening tests for common infectious diseases, food intolerances, sexually transmitted infections, and more tests that are in the development stage.

## Funding rounds

- Series B, Jul 9, 2024, $23M — LabCorp Ventures, DigitalDx Ventures, Kompass Kapital
- Series B, Jan 9, 2024, $15M — LabCorp Ventures, DigitalDx Ventures

## Investors

- LabCorp Ventures (https://capitalatlas.ai/funds/labcorp-ventures) — Series B
- DigitalDx Ventures (https://capitalatlas.ai/funds/digitaldx-ventures) — Series B
- Kompass Kapital (https://capitalatlas.ai/funds/kompass-kapital) — Series B